Skip to main content

Biotech and Delisting Risk From China’s Perspective with WisdomTree

Liqian Ren, Ph.D., and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D., co-founder and CEO of Adagene, regarding developments in the pharmaceutical industry and business practices abroad in the most recent China of Tomorrow podcast from WisdomTree. Adagene is a biotech...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.